# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Paper details vaccine design optimization process of Gritstone's "off-the-shelf" or shared neoantigen vaccine pla...
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dipping over 1% on Tuesday. The Dow traded down ...
JMP Securities analyst Roy Buchanan maintains Gritstone Bio (NASDAQ:GRTS) with a Market Outperform and raises the price targ...
Shares of Stryve Foods, Inc. (NASDAQ: SNAX) fell sharply during Tuesday’s session following a fourth-quarter revenue miss.
U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling more than 1% on Tuesday. The Dow traded dow...
Preliminary data released by Gritstone bio reveals results for GRANITE, a personalized neoantigen cancer vaccine, in treating m...
U.S. stocks traded lower this morning, with the Dow Jones index falling more than 400 points on Tuesday. Following the market ...